Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37

Benzinga Newsdesk www.benzinga.com Negative 92.5%

Neg 92.5% Neu 0% Pos 0%

Wedbush analyst Michael Piccolo maintains Staar Surgical (NASDAQ:STAA) with a Outperform and lowers the price target from $40 to $37.